LeMaitre Vascular · Q1 FY2026 call record电话会记录
“We are increasing our annual guidance for gross margin to 72.3% and operating to $79.8 million, representing 24% growth over adjusted 2025 operating income.”
A live archive of receipt-bound excerpts from company earnings calls. No generated thesis, no recommendation — just the recorded language, its source coordinates, and a direct path into the ticker dossier or live Terminal.来自公司财报电话会的可追溯摘录档案。没有生成式投资结论,也没有推荐——只有原始表述、来源坐标,以及进入个股档案或实时终端的直接入口。
Start free in Terminal免费开始使用终端50 verified call records份已核验电话会记录 · 600 exact facts条精确事实 · 2026-09-07 → 2026-09-13
Browse the full archive page by page. Search on this page by ticker, period, category, or speaker; every card preview is a verbatim call excerpt.分页浏览完整档案。在本页按代码、期间、分类或发言人搜索;每张卡片预览均为电话会原文摘录。
Showing records 4225–4320 of 5581.显示第 4225–4320 条,共 5581 条。
“We are increasing our annual guidance for gross margin to 72.3% and operating to $79.8 million, representing 24% growth over adjusted 2025 operating income.”
“Turning to our non-GAAP results, third quarter gross margin was 47.9%, which was up 540 basis points sequentially, up 1,270 basis points year-over-year, due to better manufacturing utilization across the majority of our product lines, increased pricing on select products, and favorable product mix.”
“Sales and marketing costs increased $7.7 million or 27.2%, primarily due to increased royalties associated with the final royalty rate step up under our National Geographic agreement and investments in demand generation efforts.”
“Maintaining our adjusted EBITDA margin guidance at mid-thirteens, raising our non-GAAP diluted EPS guidance of by $0.05, yielding $12.10-$12.50, and increasing our operating cash flow guidance by $50 million to approximately $1.8 billion.”
“Pull-through weighted rate lock volume came in within the guidance we issued last quarter of $7.75 billion to $8.75 billion, and contributed to adjusted total revenue of $299 million, which compared to $316 million in the fourth quarter of 2025.”
“Despite the subdued industry backdrop, driven by our self-help initiatives and growth platforms, we continue to expect full-year revenue of $4.2 billion-$4.3 billion and an operating profit margin in the range of 7.5%-8%.”
“Among the highlights, first, we expanded our partnership with Uber to provide a minimum of 35,000 Robotaxis, up from 20,000 previously announced, and increased their investment to $500 million, up from $300 million, improving our visibility into long-term demand and revenue in a new and growing market.”
“We're also raising our full year 2026 non-GAAP operating income guidance to a range of $222 million-$228 million, a non-GAAP operating margin of approximately 14.5%-15%.”
“The company exited the quarter with around $500 million of liquidity post these transactions, with additional liquidity to be created from the EG sale and from free cash flow going forward.”
“Starting with aggregates, our 26% volume growth, coupled with price increases and cost controls, drove strong margin improvement.”
“To give you a sense of the embedded profitability, as we've done the last couple of quarters, our insurance operating earnings would have been slightly north of $300 million in Q1 if we included the impact of marks on investments where a significant portion of the return relates to appreciation rather than cash yield.”
“Taken together, this results in revenue phasing of approximately 47% in the first half and 53% in the second half, reflecting a relatively stable Mission Tech run rate and second half growth in Sustainable Tech as customer activity normalizes and recent wins ramp, particularly in regions impacted by the Middle East disruptions.”
“Service levels and customer demand remain consistent, and Q1 puts us on a solid trajectory toward our full-year revenue guidance of $105 million-$115 million.”
“Putting this all together, we expect our revenue to grow at a three year organic compound annual rate of 5%-7%, and we are targeting an adjusted EBITDA margin of 20% in 2028, supported by our margin enhancement initiatives and volume growth.”
“Our 2026 full year guidance does include assumptions that generics will build volumes in the second half of the year, as well as the potential for the entry of new wake-promoting agents entering the market in the second half of the year in the NT1 narcolepsy segment.”
“In the first quarter, we reduced our share count by about 4%, buying back $535 million of stock, and we expect to generate significant free cash flow and have fewer shares outstanding over the course of the next several years.”
“One quarter of bookings, $2.5 billion of bookings that are gonna be to revenue over the next four to seven years, is not going to affect our margins, one bit.”
“And adjusted EBITDA totaled $49 million, with an adjusted EBITDA margin of 21%, well above the high end of our guidance range.”
“Turning to our guidance, for the fourth quarter of fiscal 2026, we expect SaaS revenue to be between $113.1 million-$114.1 million.”
“Following up on your 2027 commentary, appreciate that you're planning to provide more details next quarter, but as you think about initial enrollment growth, what are your initial thoughts on your aggregate patient risk scores and new member acuity mix?”
“Turning to our Q1 net sales bridge, the 1% decrease was driven by $32 million in lower volume and $22 million in lower price mix, partially offset by $33 million of favorable foreign exchange translational impacts.”
“In addition, we are working on several secured and unsecured financing transactions that have not yet closed, totaling nearly $130 million, including a $56.5 million financing at a rate of 8.75% that we expect to be funded today.”
“Our first quarter revenues were $392 million, representing an increase of 2.4% on a reported basis and an organic increase of 1.3%, reflecting continued strong demand for our portfolio, improved supply, increased visibility, and strong performance in Tissue Reconstruction.”
“As Mark mentioned, today we affirm our annual RVR margin and adjusted EPS guidance, which includes RVR in a range of $1.78 billion-$1.86 billion, adjusted EBITDA in a range of 14.5%-15% of RVR, and adjusted non-GAAP EPS in a range of $8.35-$9.15.”
“As we have consistently communicated throughout 2025, we have increased leverage to support our continued growth and return objectives, allowing us to continue to focus on what we believe are high-quality originations versus chasing higher yielding assets with more risk.”
“For the second quarter, we expect our revenue growth rate will approximate 9.5% and adjusted EBITDA margin will approximate 23%.”
“Our growth outlook, combined with the progress made on value creation initiatives and a strong start to the year, reinforces my confidence and my commitment that we will deliver on our 2026 financial guidance.”
“We continue to target a dividend payout ratio for 2026 of 50% of earnings per ordinary share, excluding material notable items and related impacts.”
“In terms of cash flow, net cash used in operating activities for the quarter was $4.2 million compared to a cash usage of $1.6 million in the first quarter of 2025.”
“From a margin standpoint, we expect to drive significant improvement in growth margins approaching 30%, while operating expenses as a percentage of sales decrease to less than 20% from the 25% in 2025.”
“Our operating margin was 25%, generating $46 million in operating income, exceeding our guidance range of $30 million-$32 million for the quarter.”
“Moving on to the second quarter look-ahead outlined on slide 8, we expect shipbuilding revenue of approximately $2.4 billion and shipbuilding operating margins between 5.7% and 6%.”
“How much growth from partnerships like Function Health and Hims & Hers are factored in your guidance for Galleri growth in 2026?”
“24 brands across our food and beverage customer base are running promotions for the World Cup, and our customers are planning for increased demand from spectators and fans.”
“Our year-over-year gross margin was slightly down by 10 basis points, reflecting the impact of incremental fuel surcharges within our outbound transportation in the back half of the quarter, as well as product mix, which was impacted by an increase in the number of large orders and projects during the quarter.”
“With approximately 2/3 of our revenue in this end market driven by premium handsets, we expect to see a more contained impact from memory pricing dynamics compared to the broader industry.”
“We are seeing a slowdown in growth in revenues and earnings.”
“We delivered same-restaurant sales growth of 2.8%, generated a restaurant level operating profit margin of 18.5%, and expanded the system to 648 restaurants with the opening of 16 new locations.”
“As a reminder, the year-over-year anticipated decline in revenue primarily reflects the impact of softer bookings in the first half of 2025, continued FSP headwinds, and anticipation of lower passthrough costs.”
“This results in an adjusted free cash flow margin of 24% and 27.5% for Q2 and full year 2026 respectively.”
“We're also increasing our guidance for full year adjusted earnings per share above our previously stated range to between $4.50 and $5 per share, reflecting the strong first quarter performance and the momentum we are seeing in our business.”
“With 10.1%, this is a solid start toward achieving our projected group operating income margin of 10.5%-12% for the full year.”
“Stock-based compensation remains targeted at approximately 10% of revenue, while we continue managing growth and net dilution in a disciplined manner and anticipates free cash flow conversion of 70%-75% of adjusted EBITDA.”
“Finally, in banking, revenue decreased 6% on an organic basis and was down 4% on an adjusted basis as we continued to be impacted by certain actions taken over the last several years, as well as higher non-recurring revenue in the year-ago period, as well as attrition that remains above our long-term target.”
“Gross profit was $89 million, reflecting lower gross Other Products and Services and prepared foods segment, where results were impacted by lower selling prices in our poultry and meats business due to softer demand and the conflict in the Middle East.”
“I just don't think the volume impact will be nearly what we saw in that 2022 timeframe.”
“Fourth, finally, we remain committed to running the business at the highest level of efficiency as we advance our R&D priorities and at the same time generate substantial free cash to invest in the pipeline through the right targeted BD at the right price to access external sources of innovation and to continue our share repurchase program, including an additional $750 million that was just authorized by the Exelixis board.”
“As a result, we expect Q2 to be our softest quarter of the year, with revenue and margins leading to an estimated Q2 revenue of $75 million-$85 million and an adjusted EBITDA loss of $12.5 million-$7.5 million.”
“Mike, the first question is regarding the outlook for political revenue in 2026.”
“As we look toward the rest of the year with an unprecedented demand backdrop, we raised our organic growth outlook by 200 basis points to a midpoint of 10% and also raised our adjusted EPS midpoint expectations to now $13.28 for the year, which covers the EPS dilution from the Boyd acquisition.”
“Looking back on the last 12 months, our consolidated copper production is up nearly 40%, and gold sales volumes, when including gold concentrates, are up 77% year-over-year.”
“As a result, the merger will be immediately accretive to earnings per share, and we expect to deliver 10%+ accretion on a run rate basis by the end of 2028, with potential upside from revenue synergies.”
“The increase of $70 million in revenue was offset by an additional $70 million in cost of sales linked to new projects and to the increase in electricity trade activity in Israel, while G&A and project development expenses increased by $6 million.”
“We are updating our full year guidance to reflect the impact of the conflict in the Middle East, and we now expect sales growth of 4.5% with underlying growth of 3%.”
“revenue as compared to our prior projections, we are lowering our adjusted operating margin guidance from a range of between 29% and 30% to a new range of between 22.25% and 23.25%.”
“Higher sales volume for both virgin sulfuric acid and regeneration services, as well as positive pricing, translated into adjusted EBITDA of $40 million, up $19 million compared to the prior year first quarter, and ahead of our previously provided guidance range.”
“As a result, we're raising our volume growth expectations for the full year from flat to a range of 25-50 basis point increase.”
“Consistent with our load forecast, we expect these customers to begin taking energy as early as the second half of 2027 and into 2028 and ramp into their full contracted load through the early 2030s.”
“We continue to expect net sales growth in the range of 7%-9%, driven by the full year impact of our pricing initiatives, along with a modest level of volume growth that we expect to be primarily in the back half of the year.”
“We expect to deliver this 2026 growth with high thirties adjusted EBITDA margins and 9%-12% adjusted free cash flow margins, which does include some start-up costs for the new 60 megawatts.”
“Gross profit was $89 million, reflecting lower gross Other Products and Services and prepared foods segment, where results were impacted by lower selling prices in our poultry and meats business due to softer demand and the conflict in the Middle East.”
“Through disciplined commercial and operational execution, we delivered organic sales growth of 2%, 130 basis points of pro forma margin expansion, and double-digit adjusted EPS growth.”
“If perhaps maybe you could remind us maybe how much you given your cash flow underwriting, what percentage of your customers are using BNPL throughout maybe the other prominent, you know, 6 to 7 logos that are out there in the U.S.?”
“As Andrew stated earlier, we saw strong demand for MYQORZO, and the net product revenue is reflective of over 70% of dispensed patients on a paid prescription, with the balance receiving drugs through either our 30-day free trial, bridge, or patient assistance programs.”
“For the quarter, we had service revenue that increased 29% to $10.6 million, and our gross margin was 63% for the quarter.”
“Coupling this with stable and persistent renter demand, investors have been drawn to the market, and we expect this to continue throughout 2026, in part due to next 12 month deliveries representing 1.6% of existing inventory and the full construction pipeline at 2.1% of inventory.”
“At current prices, we expect to generate approximately $1 billion of Levered Free Cash Flow in 2026, which gives us the ability to reduce debt, fund accretive M&A, and repurchase shares when appropriate.”
“Spread income increased by 1%, which is in line with our guidance around the earning of the majority of the 2025 Fed rate cuts.”
“This represents a contraction of roughly 300 basis points year-over-year and 270 basis points quarter-over-quarter, driven primarily by the gross profit dynamics I just described, along with the near-term pressure from operating costs that were sized for a pre-incident demand curve.”
“Based on the increased realization of the target, we now expect about $130 million to be realized through the P&L and $70 million expected to be realized as a CapEx synergy.”
“In China, we now expect total revenue, including joint ventures, to increase 10% in 2026, an improvement from prior outlook of down 1% driven by stronger data center demand.”
“We also increased our financial flexibility through a $400 million long-term debt financing and an extension of our revolving credit facility supporting the acquisition of Ayesa Engineering, which we expect to close later this quarter.”
“In 2035, we expect to have approximately $892 million of contracted net operating income.”
“Quarterly performance in our sector always reflects the variable timing of customer deliveries and the sales mix, and Q1 2026 was no exception.”
“Turning to guidance, we are raising our full year 2026 revenue range to be between $72 million and $77 million revenue, representing 48% growth at the midpoint over full year 2025.”
“From a loan performance standpoint, forecasted net cash flows from our loan portfolio declined $9.1 million, or 0.1% during the quarter, versus a decline of $34.2 million, or 0.3% last quarter, reflecting reduced volatility and forecast changes.”
“Total volumes increased by 0.8% and EBITDA increased by 5.3% with flattish margins as disciplined revenue and cost management enabled increased sales and marketing investments and offset transactional headwinds.”
“Costs were higher than our guidance at $142 per ton, largely due to lower volumes at Centurion, partially offset by realized prices that increased 13% quarter-over-quarter.”
“Looking ahead, we view 2026 as a year of production growth compared to 2025 as development across our core areas continues to ramp, and we maintain our production guidance outlined in February.”
“Our updated adjusted EBITDA margin outlook is 14%, inclusive of 50 basis points of impact from the Q2 inventory-related charge.”
“Our current product offering is targeted at SME E&S customers in construction and real estate, where we provide primary general liability coverage for hard-to-place risks with minimum premiums below $1,000.”
“For the second quarter, we expect total revenue in the range of $205 million-$213 million, including Bumble app revenue of $168 million-$174 million, and Adjusted EBITDA of $65 million-$70 million, representing a margin of approximately 32% at the midpoint.”
“Consistent with past practice and given the early stage of the hydrogen fuel cell market, we are not providing specific revenue or net income guidance for 2026.”
“Looking ahead, we anticipate a modest revenue headwind of roughly $1 million-$2 million over the balance of the year due to FX.”
“We expect occupancy and operating expenses to be approximately 23% of sales in Q2 as we reinvest the marketing favorability captured in Q1 to drive sales performance in our high-volume celebration season.”
“If we think about Australia just standing alone, it has a full year revenue profile that's in the neighborhood of around $140 million of revenue, and with losses in the $20 million-$25 million range in total, it's about 150 basis points of overall headwind to the full service business.”
“Sequentially, our plywood sales volumes were up 5% fourth quarter 2025, as anticipated, due to seasonal demand improvement.”
“Overall, we have increased our backlog from Q4 by 14% to $281.9 million while substantially improving our gross margin.”
“For 2026, with the inclusion of Benepack, we continue to expect volume growth above the top end of our long-term 3%-5% range, along with operating leverage of 2x.”
“Our guidance includes expected negative impact from the energy recovery mechanism or ERM of $0.10 in 90% customer, 10% company sharing band.”
“Accordingly, we expect Q2 revenue to be in the range of $50,000-$100,000.”
“For the full year, we expect net sales to be in the range of $2.9 billion-$2.95 billion.”
“To put our first quarter financial performance in perspective, we drove 14% overall revenue growth and 17% surgical revenue growth at an annualized scale of approximately $800 million, with strong operating leverage translating into significant profitability expansion while making material improvements to our balance sheet.”
“Revenues of $5.1 billion grew at an adjusted rate of 1%, driven by strength at EDS, while new Aptiv absorbed certain customer mix headwinds, but importantly progressed in diversifying revenues with 9% growth in non-automotive and 10% growth in software and services.”
“Preliminary reports for the month of April indicate comparable hotels RevPAR growth of over 4%, supported by continued strength in demand and the benefit of favorable year-over-year comparisons related to the negative effects of DOGE, Liberation Day, and the resulting general macroeconomic uncertainty.”
“Arista is a shining example here with greater than 100 cumulative customers to date in 800 GB Ethernet deployments, and we expect the addition of 1.6 TB in 2027 at production scale.”
Try a ticker, period, category, or a call speaker.请尝试代码、期间、分类或电话会发言人。
This is a transcript-only, historically incomplete publication. Releases, filings, slides, consensus and price reaction are visibly marked as not joined; lower-evidence packets remain held instead of being inferred.这是仅基于电话会文本且历史覆盖尚不完整的发布。新闻稿、披露文件、演示材料、一致预期和股价反应均明确标注为未接入;证据不足的数据包会被暂缓,而非由推断补齐。